Testosterone Deprivation Impairs Cardiac Systolic Function in Orchiectomized Wistar Rats

Abstract

Several studies have linked low levels of testosterone with increased symptoms of cardiac disease and cardiovascular mortality; however, the effects of testosterone deficiency on cardiac systolic function and morphology are still not completely elucidated. The present study aims to evaluate the influence of testosterone deprivation on cardiac systolic function and morphology. Male Wistar rats were divided into two groups: Sham operation group (Sham): animals underwent sham operation and Orchiectomized group (Orchiec): animals underwent bilateral orchiectomy. The experimental protocol lasted 60 days after the surgery. All animals were weighted and blood samples collected to serum testosterone analysis, determined by chemiluminescence, on first (before orchiectomy) and on 60th days. One day before euthanasia (on the 59th day) echocardiographic parameters were assessed to evaluate left ventricle (LV) systolic function and morphology. Statistical significant difference was set at≤0.05. Orchiec rats presented reduced LV fractional shortening (p=0.032), increased myocardial performance index (MPI) (p=0.043), prolonged mitral valve closure time (p=0.013) and decreased heart rate (p=0.049) when compared to Sham. No statistically significant difference was found in the ejection fraction (p=0.666) between groups. Besides that, heart weight was lower in Orchiec group (p=0.035) when compared to Sham group. Testosterone deprivation reduced cardiac systolic function, changing contraction and relaxation parameters. Testosterone deficiency also changed heart rate and heart weight. The present study demonstrated for the first time that castrated levels of testosterone could alter parameters such as mitral valve closing time and MPI.

Keywords

testosterone deprivation - echocardiography - cardiac systolic function

Publikationsverlauf

Eingereicht: 17. November 2024

Angenommen nach Revision: 24. März 2025

Artikel online veröffentlicht:
22. April 2025

• References

• 1 Traish AM. Adverse health effects of testosterone deficiency (TD) in men. Steroids 2014; 88: 106-116
• 2 Gagliano-Jucá T, Basaria S. Testosterone replacement therapy and cardiovascular risk. Nat Rev Cardiol 2019; 16: 555-574
• 3 Basaria S, Coviello AD, Travison TG. et al. Adverse events associated with testosterone administration. N Engl J Med 2010; 363: 109-122
• 4 Alkamel A, Shafiee A, Jalali A. et al. The association between premature coronary artery disease and level of testosterone in young adult males. Arch Iran Med 2014; 17: 545-550
• 5 Basaria S, Harman SM, Travison TG. et al. Effects of testosterone administration for 3 years on subclinical atherosclerosis progression in older men with low or low-normal testosterone levels: a randomized clinical trial. JAMA 2015; 314: 570-581
• 6 Zeller T, Appelbaum S, Kuulasmaa K. et al. Predictive value of low testosterone concentrations regarding coronary heart disease and mortality in men and women - evidence from the FINRISK97 study. J Intern Med 2019; 286: 317-325
• 7 Araujo AB, Kupelian V, Page ST. et al. Sex steroids and all-cause and cause-specific mortality in men. Arch Intern Med 2007; 167: 1252-1260
• 8 Fode M, Salonia A, Minhas S. et al. Late-onset hypogonadism and testosterone therapy – a summary of guidelines from the American urological association and the European association of urology. Eur Urol Focus 2019; 5: 539-544
• 9 Lincoff AM, Bhasin S, Flevaris P. et al. TRAVERSE study investigators. Cardiovascular safety of testosterone-replacement therapy. N Engl J Med 2023; 389: 107-117
• 10 Windfeld-Mathiasen J, Heerfordt IM, Dalhoff KP. et al. Mortality among users of anabolic steroids. JAMA 2024; 331: 1229-1230
• 11 Hu JR, Duncan MS, Morgans AK. et al. Cardiovascular effects of androgen deprivation therapy in prostate cancer: contemporary Meta-analyses. Arterioscler Thromb Vasc Biol 2020; 40: e55-e64
• 12 Dalpiaz PL, Lamas AZ, Caliman IF. et al. Sex hormones promote opposite effects on ACE and ACE2 activity, hypertrophy and cardiac contractility in spontaneously hypertensive rats. PLoS One 2015; 10: e0127515
• 13 Tsai WC, Yang LY, Chen YC. et al. Ablation of the androgen receptor gene modulates atrial electrophysiology and arrhythmogenesis with calcium protein dysregulation. Endocrinology 2013; 154: 2833-2842
• 14 Golden KL, Marsh JD, Jiang Y. Castration reduces mRNA levels for calcium regulatory proteins in rat heart. Endocrine 2002; 19: 339-344
• 15 Tsang S, Wong SS, Wu S. et al. Testosterone-augmented contractile responses to alpha1- and beta1-adrenoceptor stimulation are associated with increased activities of RyR, SERCA, and NCX in the heart. Am J Physiol Cell Physiol 2009; 296: C766-C782
• 16 Witayavanitkul N, Woranush W, Bupha-Intr T. et al. Testosterone regulates cardiac contractile activation by modulating SERCA but not NCX activity. Am J Physiol Heart Circ Physiol 2013; 304: H465-H472
• 17 Hsu JC, Cheng CC, Kao YH. et al. Testosterone regulates cardiac calcium homeostasis with enhanced ryanodine receptor 2 expression through activation of TGF-β. Int J Cardiol 2015; 190: 11-14
• 18 Sebag IA, Gillis MA, Calderone A. et al. Sex hormone control of left ventricular structure/function: mechanistic insights using echocardiography, expression, and DNA methylation analyses in adult mice. Am J Physiol Heart Circ Physiol 2011; 301: H1706-H1715
• 19 Salem JE, Alexandre J, Bachelot A. et al. Influence of steroid hormones on ventricular repolarization. Pharmacol Ther 2016; 167: 38-47
• 20 Malkin CJ, Pugh PJ, Jones RD. et al. The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men. J Clin Endocrinol Metab 2004; 89: 3313-3318
• 21 Pongkan W, Chattipakorn SC, Chattipakorn N. Chronic testosterone replacement exerts cardioprotection against cardiac ischemia-reperfusion injury by attenuating mitochondrial dysfunction in testosterone-deprived rats. PLoS One 2015; 10: e0122503
• 22 Eleawa SM, Sakr HF, Hussein AM. et al. Effect of testosterone replacement therapy on cardiac performance and oxidative stress in orchidectomized rats. Acta Physiol (Oxf) 2013; 209: 136-147
• 23 Ayaz O, Banga S, Heinze-Milne S. et al. Long-term testosterone deficiency modifies myofilament and calcium-handling proteins and promotes diastolic dysfunction in the aging mouse heart. Am J Physiol Heart Circ Physiol 2019; 316: H768-H780
• 24 Kanar BG, Ozben B, Sunbul M. et al. Androgen-deprivation therapy impairs left ventricle functions in prostate cancer patients. Int Urol Nephrol 2019; 51: 1107-1112
• 25 Hydock DS, Wonders KY, Schneider CM. et al. Androgen deprivation therapy and cardiac function: effects of endurance training. Prostate Cancer Prostatic Dis 2006; 9: 392-398
• 26 National Research Council. 2011. Guide for the Care and Use of Laboratory Animals: Eighth Edition. Washington, DC: The National Academies Press. https://doi.org/10.17226/12910
• 27 Tavares AM, da Rosa Araujo AS, Llesuy S. et al. Early loss of cardiac function in acute myocardial infarction is associated with redox imbalance. Exp Clin Cardiol 2012; 17: 263-267
• 28 Gottdiener JS, Bednarz J, Devereux R. et al. American society of echocardiography. American society of echocardiography recommendations for use of echocardiography in clinical trials. J Am Soc Echocardiogr 2004; 17: 1086-1119
• 29 de Castro AL, Tavares AV, Fernandes RO. et al. T3 and T4 decrease ROS levels and increase endothelial nitric oxide synthase expression in the myocardium of infarcted rats. Mol Cell Biochem 2015; 408: 235-243
• 30 Weerateerangkul P, Shinlapawittayatorn K, Palee S. et al. Early testosterone replacement attenuates intracellular calcium dyshomeostasis in the heart of testosterone-deprived male rats. Cell Calcium 2017; 67: 22-30
• 31 Gottdiener JS, Bednarz J, Devereux R. et al. A report from the American society of echocardiography’s guidelines and standards committee and the task force on echocardiography in clinical trials. J Am Soc Echocardiogr 2004; 17: 1086-1119
• 32 Hussein MF, Al-Mayahi SR, Essa SI. The role of myocardial performance index in assessment of left ventricular function in patients with valvular mitral regurgitation. Int J Cardiol 2017; 230: 25-27
• 33 Uemura K, Kawada T, Zheng C. et al. Myocardial performance index is sensitive to changes in cardiac contractility, but is also affected by vascular load condition. Annu Int Conf IEEE Eng Med Biol Soc 2013; 695-698
• 34 Cury AF, Bonilha A, Saraiva R. et al. Myocardial performance index in female rats with myocardial infarction: relationship with ventricular function parameters by Doppler echocardiography. J Am Soc Echocardiogr 2005; 18: 454-460
• 35 Dujardin KS, Tei C, Yeo TC. et al. Prognostic value of a Doppler index combining systolic and diastolic performance in idiopathic-dilated cardiomyopathy. Am J Cardiol 1998; 82: 1071-1076
• 36 Tei C, Ling LH, Hodge DO. et al. New index of combined systolic and diastolic myocardial performance: a simple and reproducible measure of cardiac function- a study in normals and dilated cardiomyopathy. J Cardiol 1995; 26: 357-366
• 37 Harjai KJ, Scoott L, Vivekananthan K. et al. The Tei index: a new prognostic index for patients with symptomatic heart failure. J Am Soc Echocardiogr 2002; 15: 864-868
• 38 Parthenakis FI, Kanakaraki MK, Kanoupakis EM. et al. Value of Doppler index combining systolic and diastolic miocardial performance in predicting cardiopulmonary exercise capacity in pacients with congestive heart failure: coll effects of dobutamine. Chest 2002; 121: 1935-1941
• 39 De Silva NL, Papanikolaou N, Grossmann M. et al. Male hypogonadism: pathogenesis, diagnosis, and management. Lancet Diabetes Endocrinol 2024; 12: 761-774
• 40 Babcock MC, DuBose LE, Hildreth KL. et al. Age-associated reductions in cardiovagal baroreflex sensitivity are exaggerated in middle-aged and older men with low testosterone. J Appl Physiol (1985) 2022; 133: 403-415
• 41 Basaria S, Coviello AD, Travison TG. et al. Adverse events associated with testosterone administration. N Engl J Med 2010; 363: 109-122